Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users
Human Abuse Liability Study in Recreational Drug Users to Investigate the Abuse Liability Potential of RO4917838
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users
Human Abuse Liability Study in Recreational Drug Users to Investigate the Abuse Liability Potential of RO4917838
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of RO4995819 in Healthy Elderly Volunteers
A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of RO4995819 Following Oral Administration in Healthy Elderly Subjects.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Miramar, FL
A Study of RO4995819 in Healthy Elderly Volunteers
A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of RO4995819 Following Oral Administration in Healthy Elderly Subjects.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
An Open-Label, Fixed-Sequence, 2-Period Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Austin, TX
Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
An Open-Label, Fixed-Sequence, 2-Period Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14c]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14c]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers
A Drug-Drug Interaction Study Between Danoprevir/Low-dose Ritonavir and Cyclosporine, a Potent Inhibitor of OATP, in Healthy Subjects
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers
A Drug-Drug Interaction Study Between Danoprevir/Low-dose Ritonavir and Cyclosporine, a Potent Inhibitor of OATP, in Healthy Subjects
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers
A Study to Evaluate the Potential Drug-Drug Interaction Between Darunavir and Danoprevir When Administered Together With Low-Dose Ritonavir in Healthy Volunteers
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers
A Study to Evaluate the Potential Drug-Drug Interaction Between Darunavir and Danoprevir When Administered Together With Low-Dose Ritonavir in Healthy Volunteers
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers
A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir When Given With Raltegravir in Healthy Adult Volunteers
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers
A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir When Given With Raltegravir in Healthy Adult Volunteers
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy Volunteers
A Study to Evaluate the Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir When Administered Together in Healthy Adult Volunteers
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy Volunteers
A Study to Evaluate the Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir When Administered Together in Healthy Adult Volunteers
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers
A Randomized, Single-center, Open-label, One-sequence, Two-period Crossover Study in 3 Parts to Investigate the Effects of Multiple Doses of Ketoconazole (Part 1), Rifampicin (Part 2), and Ritonavir-boosted Atazanavir (Part 3) on the PK of a Single Dose of RO5093151 in Healthy Female & Male Subjects
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Merritt Island, FL
A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers
A Randomized, Single-center, Open-label, One-sequence, Two-period Crossover Study in 3 Parts to Investigate the Effects of Multiple Doses of Ketoconazole (Part 1), Rifampicin (Part 2), and Ritonavir-boosted Atazanavir (Part 3) on the PK of a Single Dose of RO5093151 in Healthy Female & Male Subjects
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Merritt Island, FL
Click here to add this to my saved trials
A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir
A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir When Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir in Healthy Adult Volunteers
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir
A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir When Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir in Healthy Adult Volunteers
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers
A Multiple-center, Multiple-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Parallel Group Study to Investigate the Effect of RO4917838 on the QTc Interval in Healthy Subjects.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Tempe, AZ
A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers
A Multiple-center, Multiple-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Parallel Group Study to Investigate the Effect of RO4917838 on the QTc Interval in Healthy Subjects.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers
A Multiple-center, Multiple-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Parallel Group Study to Investigate the Effect of RO4917838 on the QTc Interval in Healthy Subjects.
Status: Enrolling
Updated:  8/1/2016
mi
from
Strasbourg,
A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers
A Multiple-center, Multiple-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Parallel Group Study to Investigate the Effect of RO4917838 on the QTc Interval in Healthy Subjects.
Status: Enrolling
Updated: 8/1/2016
mi
from
Strasbourg,
Click here to add this to my saved trials
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0973 Following Single Oral Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madison, WI
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0973 Following Single Oral Dose Administration in Healthy Male Subjects
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of RO6870868 in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacodynamics and the Effect of Food on the Pharmacokinetics of RO6870868
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Marlton, NJ
A Study of RO6870868 in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacodynamics and the Effect of Food on the Pharmacokinetics of RO6870868
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy Volunteers
A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF FORMULATION AND TABLET HARDNESS ON THE RELATIVE BIOAVAILABILITY OF PICTILISIB (GDC-0941) IN HEALTHY SUBJECTS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madison, WI
A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy Volunteers
A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF FORMULATION AND TABLET HARDNESS ON THE RELATIVE BIOAVAILABILITY OF PICTILISIB (GDC-0941) IN HEALTHY SUBJECTS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers
A Single-center, Randomized Open-label, Single-dose, Parallel Group Study to Investigate the Relative Bioavailability of a High Concentration Liquid Formulation (Hclf) in Prefilled Syringes Versus the Reference Lyophilized Formulation (Lyof) of Gantenerumab Following Administration by Subcutaneous Injection in Healthy Volunteers
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers
A Single-center, Randomized Open-label, Single-dose, Parallel Group Study to Investigate the Relative Bioavailability of a High Concentration Liquid Formulation (Hclf) in Prefilled Syringes Versus the Reference Lyophilized Formulation (Lyof) of Gantenerumab Following Administration by Subcutaneous Injection in Healthy Volunteers
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation
A PHASE 1, OPEN-LABEL, SINGLE-DOSE, RANDOMIZED, 2-PERIOD, 2-TREATMENT SEQUENCE CROSS-OVER STUDY TO ASSESS THE RELATIVE BIOAVAILABILITY OF COBIMETINIB ADMINISTERED AS A TABLET FORMULATION COMPARED TO A CAPSULE FORMULATION IN HEALTHY SUBJECTS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Dallas, TX
A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation
A PHASE 1, OPEN-LABEL, SINGLE-DOSE, RANDOMIZED, 2-PERIOD, 2-TREATMENT SEQUENCE CROSS-OVER STUDY TO ASSESS THE RELATIVE BIOAVAILABILITY OF COBIMETINIB ADMINISTERED AS A TABLET FORMULATION COMPARED TO A CAPSULE FORMULATION IN HEALTHY SUBJECTS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 1 Study of RO6806127 in Healthy Male Volunteers
A Single-center, Randomised, Double-blind, Adaptative, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food), and Pharmacodynamics or RO6806127 in Healthy Male Subjects
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Marlton, NJ
A Phase 1 Study of RO6806127 in Healthy Male Volunteers
A Single-center, Randomised, Double-blind, Adaptative, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food), and Pharmacodynamics or RO6806127 in Healthy Male Subjects
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose
A Phase 1, Single-Dose, Randomized, Open-Label, Parallel Group Study to Assess the Relative Bioavailability and Tolerability of Two Formulations of Crenezumab in Healthy Subjects Following Subcutaneous Administration
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Evansville, IN
A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose
A Phase 1, Single-Dose, Randomized, Open-Label, Parallel Group Study to Assess the Relative Bioavailability and Tolerability of Two Formulations of Crenezumab in Healthy Subjects Following Subcutaneous Administration
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose
A Phase 1, Single-Dose, Randomized, Open-Label, Parallel Group Study to Assess the Relative Bioavailability and Tolerability of Two Formulations of Crenezumab in Healthy Subjects Following Subcutaneous Administration
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Dallas, TX
A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose
A Phase 1, Single-Dose, Randomized, Open-Label, Parallel Group Study to Assess the Relative Bioavailability and Tolerability of Two Formulations of Crenezumab in Healthy Subjects Following Subcutaneous Administration
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants
A Phase I, Open-Label, Randomized, Four-Treatment Period, Four-Sequence, Single-Dose, Crossover, Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Merritt Island, FL
A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants
A Phase I, Open-Label, Randomized, Four-Treatment Period, Four-Sequence, Single-Dose, Crossover, Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Merritt Island, FL
Click here to add this to my saved trials
A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers
Randomized, Observer-blind, Placebo-controlled, Four-way Cross-over Study to Study the Ability of Functional Magnetic Resonance Imaging (fMRI) of the Brain to Detect and Characterize the Effects of Single Doses of a Selective Serotonin Reuptake Inhibitor (Escitalopram [Lexapro]), a Dopamine
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
La Jolla, CA
A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers
Randomized, Observer-blind, Placebo-controlled, Four-way Cross-over Study to Study the Ability of Functional Magnetic Resonance Imaging (fMRI) of the Brain to Detect and Characterize the Effects of Single Doses of a Selective Serotonin Reuptake Inhibitor (Escitalopram [Lexapro]), a Dopamine
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Escalating Doses of Intravenous Zidebactam in Healthy Adult Human Subjects
Status: Enrolling
Updated:  8/3/2016
Quintiles, Inc.
mi
from
Overland Park, KA
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Escalating Doses of Intravenous Zidebactam in Healthy Adult Human Subjects
Status: Enrolling
Updated: 8/3/2016
Quintiles, Inc.
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy Participants
A PHASE 1, OPEN-LABEL, SINGLE-ARM STUDY IN HEALTHY SUBJECTS TO EVALUATE PAIN, TOLERABILITY, SAFETY, AND USABILITY OF A PREFILLED AUTOINJECTOR TO SELF-ADMINISTER ETROLIZUMAB SUBCUTANEOUSLY
Status: Enrolling
Updated:  8/4/2016
Clinical Research Facility
mi
from
Cypress, CA
A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy Participants
A PHASE 1, OPEN-LABEL, SINGLE-ARM STUDY IN HEALTHY SUBJECTS TO EVALUATE PAIN, TOLERABILITY, SAFETY, AND USABILITY OF A PREFILLED AUTOINJECTOR TO SELF-ADMINISTER ETROLIZUMAB SUBCUTANEOUSLY
Status: Enrolling
Updated: 8/4/2016
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy Participants
A PHASE 1, OPEN-LABEL, SINGLE-ARM STUDY IN HEALTHY SUBJECTS TO EVALUATE PAIN, TOLERABILITY, SAFETY, AND USABILITY OF A PREFILLED AUTOINJECTOR TO SELF-ADMINISTER ETROLIZUMAB SUBCUTANEOUSLY
Status: Enrolling
Updated:  8/4/2016
Clinical Research Facility
mi
from
Dallas, TX
A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy Participants
A PHASE 1, OPEN-LABEL, SINGLE-ARM STUDY IN HEALTHY SUBJECTS TO EVALUATE PAIN, TOLERABILITY, SAFETY, AND USABILITY OF A PREFILLED AUTOINJECTOR TO SELF-ADMINISTER ETROLIZUMAB SUBCUTANEOUSLY
Status: Enrolling
Updated: 8/4/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Development of a Translational Tool to Study Yoga Therapy
Development of a Translational Tool to Study Yoga Therapy
Status: Enrolling
Updated:  8/9/2016
Crystal Park
mi
from
Storrs, CT
Development of a Translational Tool to Study Yoga Therapy
Development of a Translational Tool to Study Yoga Therapy
Status: Enrolling
Updated: 8/9/2016
Crystal Park
mi
from
Storrs, CT
Click here to add this to my saved trials
Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women
A Randomized, Controlled, Crossover Study to Evaluate the Acute Bioavailability of Eicosapentaenoic Acid andDocosahexaenoic Acid From a DietarySupplement in Healthy Men and Women: A 72-Hour Study With Controlled Feeding
Status: Enrolling
Updated:  8/11/2016
Biofortis Clinical Research
mi
from
Addison, IL
Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women
A Randomized, Controlled, Crossover Study to Evaluate the Acute Bioavailability of Eicosapentaenoic Acid andDocosahexaenoic Acid From a DietarySupplement in Healthy Men and Women: A 72-Hour Study With Controlled Feeding
Status: Enrolling
Updated: 8/11/2016
Biofortis Clinical Research
mi
from
Addison, IL
Click here to add this to my saved trials
Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Pneumococcal Opsonophagocytic Assay Development.
Status: Enrolling
Updated:  8/16/2016
Frontage Clinical Services Inc.
mi
from
Secaucus, NJ
Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Pneumococcal Opsonophagocytic Assay Development.
Status: Enrolling
Updated: 8/16/2016
Frontage Clinical Services Inc.
mi
from
Secaucus, NJ
Click here to add this to my saved trials
Effect of Clemastine Fumarate on Color Vision in Healthy Controls
Status: Enrolling
Updated:  8/16/2016
Sandler Neurosciences Building, Neurological Clinical Research Unit
mi
from
San Francisco, CA
Effect of Clemastine Fumarate on Color Vision in Healthy Controls
Status: Enrolling
Updated: 8/16/2016
Sandler Neurosciences Building, Neurological Clinical Research Unit
mi
from
San Francisco, CA
Click here to add this to my saved trials
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated:  8/23/2016
The Medical Research Network, LLC
mi
from
New York, NY
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated: 8/23/2016
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Status: Enrolling
Updated:  9/15/2016
USF Carol and Frank Morsani Center for Advanced Healthcare
mi
from
Tampa, FL
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Status: Enrolling
Updated: 9/15/2016
USF Carol and Frank Morsani Center for Advanced Healthcare
mi
from
Tampa, FL
Click here to add this to my saved trials
The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold
The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold: A Randomized, Double Blinded, Crossover Volunteer Study
Status: Enrolling
Updated:  9/21/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold
The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold: A Randomized, Double Blinded, Crossover Volunteer Study
Status: Enrolling
Updated: 9/21/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Beverly Hills, CA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Burbank, CA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Jacksonville, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Miami, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
North Miami, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Orlando, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Smyrna, GA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Rockville, MD
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
New York, NY
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Philadelphia, PA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Lake Jackson, TX
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
La Plata/Buenos Aires,
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
La Plata/Buenos Aires,
Click here to add this to my saved trials
A Study of LY3337641 in Healthy Male Participants
Disposition of [¹⁴C]-LY3337641 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated:  11/17/2016
Covance Clinical Research Unit
mi
from
Madison, WI
A Study of LY3337641 in Healthy Male Participants
Disposition of [¹⁴C]-LY3337641 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated: 11/17/2016
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
A Phase 1, Open-label, Three-period, Fixed-sequence Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects
Status: Enrolling
Updated:  11/21/2016
Quintiles, Inc.
mi
from
Overland Park, KA
A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
A Phase 1, Open-label, Three-period, Fixed-sequence Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects
Status: Enrolling
Updated: 11/21/2016
Quintiles, Inc.
mi
from
Overland Park, KA
Click here to add this to my saved trials
Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding
Use of Recombinant FVIIa to Mitigate Clopidogrel Anti-platelet Therapy-Mediated Bleeding in a Single Centre, Randomized, Placebo-controlled, Double-blind Clinical Trial
Status: Enrolling
Updated:  11/22/2016
Novo Nordisk Investigational Site
mi
from
Neptune, NJ
Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding
Use of Recombinant FVIIa to Mitigate Clopidogrel Anti-platelet Therapy-Mediated Bleeding in a Single Centre, Randomized, Placebo-controlled, Double-blind Clinical Trial
Status: Enrolling
Updated: 11/22/2016
Novo Nordisk Investigational Site
mi
from
Neptune, NJ
Click here to add this to my saved trials